Literature DB >> 2641790

Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients.

R Mukhopadhyaya1, R J Tatake, N Krishnan, R S Rao, A R Fakih, S L Naik, S G Gangal.   

Abstract

Lymphocytes from metastatic (met) and nonmetastatic (non-met) regional lymph nodes, LNL peripheral blood (PBL) and tumor infiltrating lymphocytes (TIL) of patients with squamous cell carcinoma of the oral cavity and healthy donors were investigated for CD3, CD4, CD8 and HNK-1 phenotypes, Natural Killer (NK) cell Activity, Antibody Dependent Cellular Cytotoxicity (ADCC) and proliferative response to mitogen (PHA). Modulation of NK cytotoxicity with recombinant Interferon alpha (IFN-alpha) was also investigated in some cases. Lymphocytes from met and non-met lymph nodes showed no variation in the percentages of CD3+, CD4+ and CD8+ cells, when compared with each other and with PBL of oral cancer patients. TIL showed significantly less proportion of CD3+ and CD4+ cells. The percentage of HNK-1+ cells was significantly lower in LNL and TIL when compared to PBL of oral cancer patients. The mitogen responses of met and non-met LNL were comparable to each other and better than that of PBL from the same patients, while, TIL showed significant impairment in mitogen responses. The NK cytotoxicity and ADCC of PBL from oral cancer patients were comparable to healthy donors which could be augmented by rIFN alpha. LNL and TIL showed almost negligible NK and ADCC activities and NK activity could not be modulated by rIFN alpha. The results thus demonstrate that in oral cancer patients, lymphocytes from three compartments viz. PBL, LNL and TIL showed differential effector functions. The metastatic status of LN did not affect the immunoreactivity of LNL.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2641790

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  6 in total

Review 1.  Combination strategies to enhance antitumor ADCC.

Authors:  Holbrook E Kohrt; Roch Houot; Aurélien Marabelle; Hearn Jay Cho; Keren Osman; Matthew Goldstein; Ronald Levy; Joshua Brody
Journal:  Immunotherapy       Date:  2012-05       Impact factor: 4.196

2.  Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.

Authors:  Anamika Bose; Tathagata Chakraborty; Krishnendu Chakraborty; Smarajit Pal; Rathindranath Baral
Journal:  Cancer Immun       Date:  2008-06-12

Review 3.  Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer.

Authors:  Yu Lei; Yuying Xie; Yee Sun Tan; Mark E Prince; Jeffrey S Moyer; Jacques Nör; Gregory T Wolf
Journal:  Oral Oncol       Date:  2016-08-21       Impact factor: 5.337

4.  Increased sMICA and TGFβ1 levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells.

Authors:  Stephan Klöß; Nicole Chambron; Tanja Gardlowski; Lubomir Arseniev; Joachim Koch; Ruth Esser; Wolfgang Glienke; Oliver Seitz; Ulrike Köhl
Journal:  Oncoimmunology       Date:  2015-05-29       Impact factor: 8.110

5.  Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma.

Authors:  Sandra Weil; Stefanie Memmer; Axel Lechner; Volker Huppert; Ariane Giannattasio; Tamara Becker; Andreas Müller-Runte; Karen Lampe; Dirk Beutner; Alexander Quaas; Ralf Schubert; Eva Herrmann; Alexander Steinle; Ulrike Koehl; Lutz Walter; Michael S von Bergwelt-Baildon; Joachim Koch
Journal:  Front Immunol       Date:  2017-04-10       Impact factor: 7.561

6.  Human stomach carcinoma-specific T cells derived from the tumour-draining lymph nodes.

Authors:  K Stulle; H P Vollmers; P Marquardt; H K Müller-Hermelink
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.